Up-regulation of vascular endothelial growth factor expression by adenosine through adenosine A2 receptors in the rat tongue treated with endotoxin

Archives of Oral Biology

Volumn 54, Issue 10, 2009, Pages 932-942

  Hara, Yaiko ^a   Kuroda, Noriyuki ^a   Inoue, Kouji ^a   Sato, Tetsuji ^a  

^a TSURUMI UNIVERSITY   (Japan)

Author keywords

Adenosine; Angiogenesis; Dendritic cells; LPS; Macrophages; Rat; Tongue; VEGF

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR; LIPOPOLYSACCHARIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; ENZYME IMMUNOASSAY; GERMFREE ANIMAL; GLOSSITIS; MACROPHAGE; MALE; METABOLISM; PHYSIOLOGY; RAT; TONGUE; UPREGULATION; VASCULARIZATION; WISTAR RAT;

ADENOSINE; ANIMALS; ANTIGEN-PRESENTING CELLS; GLOSSITIS; IMMUNOENZYME TECHNIQUES; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; RECEPTORS, ADENOSINE A2; SPECIFIC PATHOGEN-FREE ORGANISMS; TONGUE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 69449091260     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2009.07.008     Document Type: Article

References (76)

1. Adair T.H., Gay W.J., and Montani J.P. Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Physiol 259 3 Part 2 (1990) R393-R404
2. Hasina R., and Lingen M.W. Angiogenesis in oral cancer. J Dent Educ 65 11 (2001) 1282-1290
3. Lin E.Y., Piepkorn M., Garcia R., Byrd D., Tsou R., and Isik F.F. Angiogenesis and vascular growth factor receptor expression in malignant melanoma. Plast Reconstr Surg 104 6 (1999) 1666-1674
4. Westphal J.R., Van't Hullenaar R., Peek R., Willems R.W., Crickard K., Crickard U., et al. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. Int J Cancer 86 6 (2000) 768-776
5. Nissen N.N., Polverini P.J., Koch A.E., Volin M.V., Gamelli R.L., and DiPietro L.A. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152 6 (1998) 1445-1452
6. Szpaderska A.M., Walsh C.G., Steinberg M.J., and DiPietro L.A. Distinct patterns of angiogenesis in oral and skin wounds. J Dent Res 84 4 (2005) 309-314
7. Bloch M.J., and Pickering T. Renal vascular disease: medical management, angioplasty, and stenting. Semin Nephrol 20 5 (2000) 474-488
8. Fischer H., Prast H., and Philippu A. Adenosine release in the ventral striatum of the rat is modulated by endogenous nitric oxide. Eur J Pharmacol 275 3 (1995) R5-R6
9. Takagi H., King G.L., Robinson G.S., Ferrara N., and Aiello L.P. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci 37 11 (1996) 2165-2176
10. Adair T.H., Montani J.P., Strick D.M., and Guyton A.C. Vascular development in chick embryos: a possible role for adenosine. Am J Physiol 256 1 Part 2 (1989) H240-H246
11. Teuscher E., and Weidlich V. Adenosine nucleotides, adenosine and adenine as angiogenesis factors. Biomed Biochim Acta 44 3 (1985) 493-495
12. Adair R.F. Fetal monitoring with adenosine administration. Ann Emerg Med 22 12 (1993) 1925
13. Bruns R.F. Adenosine receptors. Roles and pharmacology. Ann N Y Acad Sci 603 (1990) 211-225 discussion 25-6
14. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76 1 (1994) 5-13
15. Meininger C.J., Schelling M.E., and Granger H.J. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol 255 3 Part 2 (1988) H554-H562
16. Bull D.A., Seftor E.A., Hendrix M.J., Larson D.F., Hunter G.C., and Putnam C.W. Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay. J Surg Res 55 5 (1993) 473-479
17. Ethier M.F., Chander V., and Dobson Jr. J.G. Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol 265 1 Part 2 (1993) H131-H138
18. Sexl V., Mancusi G., Baumgartner-Parzer S., Schutz W., and Freissmuth M. Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors. Br J Pharmacol 114 8 (1995) 1577-1586
19. Olah M.E., and Stiles G.L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 35 (1995) 581-606
20. Pinhal-Enfield G., Ramanathan M., Hasko G., Vogel S.N., Salzman A.L., Boons G.J., et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2,4,7 and 9 and adenosine A(2A) receptors. Am J Pathol 163 2 (2003) 711-721
21. Leibovich S.J., Chen J.F., Pinhal-Enfield G., Belem P.C., Elson G., Rosania A., et al. Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am J Pathol 160 6 (2002) 2231-2244
22. Macedo L., Pinhal-Enfield G., Alshits V., Elson G., Cronstein B.N., and Leibovich S.J. Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol 171 6 (2007) 1774-1788
23. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 4935 (1989) 1306-1309
24. Berse B., Brown L.F., Van de Water L., Dvorak H.F., and Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3 2 (1992) 211-220
25. Senger D.R., Perruzzi C.A., Feder J., and Dvorak H.F. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46 11 (1986) 5629-5632
26. Dvorak H.F., Sioussat T.M., Brown L.F., Berse B., Nagy J.A., Sotrel A., et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 174 5 (1991) 1275-1278
27. Plate K.H., Breier G., Weich H.A., and Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359 6398 (1992) 845-848
28. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 1 (1997) 4-25
29. Dvorak H.F., Nagy J.A., Feng D., Brown L.F., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237 (1999) 97-132
30. Brown G.M., Brown D.M., and Donaldson K. Persistent inflammation and impaired chemotaxis of alveolar macrophages on cessation of dust exposure. Environ Health Perspect 97 (1992) 91-94
31. Fava R.A., Olsen N.J., Spencer-Green G., Yeo K.T., Yeo T.K., Berse B., et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180 1 (1994) 341-346
32. Ferrara N. Leukocyte adhesion. Missing link in angiogenesis. Nature 376 6540 (1995) 467
33. Flamme I., Frolich T., and Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173 2 (1997) 206-210
34. Fehrenbach H., Haase M., Kasper M., Koslowski R., Schuh D., and Muller M. Alterations in the immunohistochemical distribution patterns of vascular endothelial growth factor receptors Flk1 and Flt1 in bleomycin-induced rat lung fibrosis. Virchows Arch 435 1 (1999) 20-31
35. Sato T., Kaneko M., Hama A., Kusakari T., and Fujieda H. Expression of class II MHC molecules in the rat pineal gland during development and effects of treatment with carbon tetrachloride. Cell Tissue Res 284 1 (1996) 65-76
36. Dickie R., Bachoo R.M., Rupnick M.A., Dallabrida S.M., Deloid G.M., Lai J., et al. Three-dimensional visualization of microvessel architecture of whole-mount tissue by confocal microscopy. Microvasc Res 72 1-2 (2006) 20-26
37. Fujimura A., Seki S., Liao M.Y., Hu X., Onodera M., and Nozaka Y. Three dimensional architecture of lymphatic vessels in the tongue. Lymphology 36 3 (2003) 120-127
38. Fujimura A., and Nozaka Y. Analysis of the three-dimensional lymphatic architecture of the periodontal tissue using a new 3D reconstruction method. Microsc Res Tech 56 1 (2002) 60-65
39. Montesinos M.C., Desai A., Chen J.F., Yee H., Schwarzschild M.A., Fink J.S., et al. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol 160 6 (2002) 2009-2018
40. Montesinos M.C., Gadangi P., Longaker M., Sung J., Levine J., Nilsen D., et al. Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med 186 9 (1997) 1615-1620
41. Montesinos M.C., Yap J.S., Desai A., Posadas I., McCrary C.T., and Cronstein B.N. Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis. Arthritis Rheum 43 3 (2000) 656-663
42. Montesinos M.C., Desai A., Delano D., Chen J.F., Fink J.S., Jacobson M.A., et al. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum 48 1 (2003) 240-247
43. Victor-Vega C., Desai A., Montesinos M.C., and Cronstein B.N. Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel). Inflammation 26 1 (2002) 19-24
44. Cronstein B.N., Kramer S.B., Weissmann G., and Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158 4 (1983) 1160-1177
45. Cronstein B.N., Rosenstein E.D., Kramer S.B., Weissmann G., and Hirschhorn R. Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol 135 2 (1985) 1366-1371
46. Cronstein B.N., Haines K.A., Kolasinski S., and Reibman J. Occupancy of G alpha s-linked receptors uncouples chemoattractant receptors from their stimulus-transduction mechanisms in the neutrophil. Blood 80 4 (1992) 1052-1057
47. Parmely M.J., Zhou W.W., Edwards III C.K., Borcherding D.R., Silverstein R., and Morrison D.C. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J Immunol 151 1 (1993) 389-396
48. Cronstein B.N., Naime D., and Firestein G. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum 38 8 (1995) 1040-1045
49. Sajjadi F.G., Takabayashi K., Foster A.C., Domingo R.C., and Firestein G.S. Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol 156 9 (1996) 3435-3442
50. Bouma M.G., van den Wildenberg F.A., and Buurman W.A. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 270 2 Part 1 (1996) C522-C529
51. Bouma M.G., Stad R.K., van den Wildenberg F.A., and Buurman W.A. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 153 9 (1994) 4159-4168
52. Boyle D.L., Sajjadi F.G., and Firestein G.S. Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum 39 6 (1996) 923-930
53. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 6797 (2000) 782-787
54. Means T.K., Golenbock D.T., and Fenton M.J. Structure and function of Toll-like receptor proteins. Life Sci 68 3 (2000) 241-258
55. Underhill D.M., and Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 14 1 (2002) 103-110
56. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 7 (2004) 499-511
57. Ferrara N., Chen H., Davis-Smyth T., Gerber H.P., Nguyen T.N., Peers D., et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4 3 (1998) 336-340
58. Xiong M., Elson G., Legarda D., and Leibovich S.J. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 153 2 (1998) 587-598
59. Crowther M., Brown N.J., Bishop E.T., and Lewis C.E. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 70 4 (2001) 478-490
60. Perez-Ruiz M., Ros J., Morales-Ruiz M., Navasa M., Colmenero J., Ruiz-del-Arbol L., et al. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide. Hepatology 29 4 (1999) 1057-1063
61. Lutty G.A., Merges C., and McLeod D.S. 5′ Nucleotidase and adenosine during retinal vasculogenesis and oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 41 1 (2000) 218-229
62. Taomoto M., McLeod D.S., Merges C., and Lutty G.A. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 41 1 (2000) 230-243
63. Grant M.B., Davis M.I., Caballero S., Feoktistov I., Biaggioni I., and Belardinelli L. Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. Invest Ophthalmol Vis Sci 42 9 (2001) 2068-2073
64. Resta R., Yamashita Y., and Thompson L.F. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 161 (1998) 95-109
65. Widnell C.C., Schneider Y.J., Pierre B., Baudhuin P., and Trouet A. Evidence for a continual exchange of 5'-nucleotidase between the cell surface and cytoplasmic membranes in cultured rat fibroblasts. Cell 28 1 (1982) 61-70
66. Hashikawa T., Takedachi M., Terakura M., Saho T., Yamada S., Thompson L.F., et al. Involvement of CD73 (ecto-5′-nucleotidase) in adenosine generation by human gingival fibroblasts. J Dent Res 82 11 (2003) 888-892
67. Savic V., Stefanovic V., Ardaillou N., and Ardaillou R. Induction of ecto-5′-nucleotidase of rat cultured mesangial cells by interleukin-1 beta and tumour necrosis factor-alpha. Immunology 70 3 (1990) 321-326
68. Siegfried G., Amiel C., and Friedlander G. Inhibition of ecto-5′-nucleotidase by nitric oxide donors, Implications in renal epithelial cells. J Biol Chem 271 9 (1996) 4659-4664
69. Rodriguez-Martinez S., Cancino-Diaz M.E., Miguel P.S., and Cancino-Diaz J.C. Lipopolysaccharide from Escherichia coli induces the expression of vascular endothelial growth factor via toll-like receptor 4 in human limbal fibroblasts. Exp Eye Res 83 6 (2006) 1373-1377
70. Murphree L.J., Sullivan G.W., Marshall M.A., and Linden J. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. Biochem J 391 Part 3 (2005) 575-580
71. van Beijnum J.R., Buurman W.A., and Griffioen A.W. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11 1 (2008) 91-99
72. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
73. Lanzavecchia A., and Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290 5489 (2000) 92-97
74. Gallucci S., and Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 13 1 (2001) 114-119
75. Panther E., Corinti S., Idzko M., Herouy Y., Napp M., la Sala A., et al. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 101 10 (2003) 3985-3990
76. Ohta A., and Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414 6866 (2001) 916-920